Blog

Seek truth from facts, competitive symbiosis

scroll down

07

2026-07

The demonstration site for the “Thousand Counties, Ten Thousand Towns” initiative has been established at the Guanyang County Traditional Chinese Medicine Hospital in Guangxi.

On July 22, the on-site exchange meeting for the “Rheumatism and Pain Triple Sequential Therapy—Thousand Counties, Ten Thousand Towns Initiative” was successfully held at the Guanyang County Traditional Chinese Medicine Hospital in Guangxi. Attending the event were Tang Peiyou, Secretary of the Party Committee of the Guanyang County Health Commission; Tang Jun, President and Party Secretary of the Guanyang County TCM Hospital; Vice Presidents Xu Siyin, Liu Zunwei, and Jiang Xiaolan; Li Yanping, Deputy Director of Academician Liu Liang’s Expert Workstation; He Zhiguo, National Project Director of the Thousand Counties, Ten Thousand Towns Initiative; staff members of the Academician Workstation; as well as leaders and key physicians from medical institutions within the Guanyang County Medical Consortium—totaling more than 100 participants.

07

2026-07

Zhengqing Group made its debut at a major event in the traditional Chinese medicine immunology sector, where an academician shared Zhengqing Fengtongning’s groundbreaking innovations.

From July 17 to 20, the 13th Annual Academic Conference of the TCM Immunology Professional Committee of the World Federation of Chinese Medicine Societies and the 2026 Expanded Meeting of the TCM Immunology Branch of the Chinese Society of Immunology were held at the Liyuan International Hotel in Nanning, Guangxi. The event brought together more than 300 experts and scholars in immunology and rheumatology from mainland China, Hong Kong, Macao, and Taiwan, focusing on cutting-edge developments in basic research and clinical translation in TCM immunology. As a vice-presidential unit of the societies, Zhengqing Group was invited to attend. Liu Liang, the group’s chief scientist and an academician of the Chinese Academy of Engineering, delivered a keynote address, offering an in-depth analysis of the core research findings behind Zhengqing Fengtongning’s innovative formulation, which drew widespread attention from the audience.

07

2026-07

All employees drive growth and navigate a new cycle | The Zhengqing Group’s Q2 2026 Amoeba Management Promotion Conference was successfully held.

On the morning of July 17, the Zhengqing Group’s second-quarter Amoeba Management Promotion Conference was held in the fifth-floor conference room at the Group’s headquarters in Huaihua. The meeting conducted a comprehensive review of the progress and results achieved in implementing the Amoeba Management model during the second quarter, outlined plans for enhancing management practices and ensuring the effective rollout of the oversight system, recognized exemplary individuals and teams, and further aligned the entire workforce around a shared vision and consensus on business operations, thereby driving the Amoeba Management approach to greater depth and practical implementation. Wu Feichi, Chairman and President of the Group, along with members of the Group’s executive team, attended the meeting. Corporate consultant Xiao Liang was invited to participate, and rotating President Long Xianjun presided over the proceedings.

07

2026-07

Good News: Zhengqing Fengtongning Sustained-Release Tablets Have Been Included in the New National Essential Medicines List, with 24 products and 38 specifications selected simultaneously!

Recently, the National Health Commission officially issued the “National Essential Medicines List (2026 Edition)” (Guo Wei Yao Zheng Fa [2026] No. 17). The new edition will be fully implemented starting September 1, 2026. The total number of items on the list has been expanded from 685 to 794, including 476 Western medicines and 318 traditional Chinese medicines, with a stronger focus on clinically essential drugs and medications for common and chronic conditions at the primary care level, thereby comprehensively improving public access to basic medicines. Hunan Zhengqing Pharmaceutical Group Co., Ltd. has had a total of 24 products across 38 specifications successfully included in the new National Essential Medicines List, comprising 3 traditional Chinese medicines and 21 chemical drugs. Its flagship product, Zhengqing Fengtongning Sustained-Release Tablets and Tablets, remains on the list, while two additional commonly used dosage forms—Acetaminophen Tablets and Acyclovir Tablets—have been added, further bolstering the company’s position in the primary‑care drug market under favorable policy support.

07

2026-07

Casting Swords on Wugong Mountain: The Six Meridians Usher in a New Era | Zhengqing Group’s 2026 Mid-Year Marketing Conference Concludes Successfully

From July 12 to 15, 2026, the Zhengqing Group’s 2026 Mid-Year Marketing Conference, themed “Forging Swords on Wugong Mountain—Six Veins Usher in a New Era,” was successfully held at the Junlan Hot Spring Hotel on Wugong Mountain in Jiangxi Province. More than 300 frontline marketing professionals and representatives from functional departments gathered on Wugong Mountain for four days of comprehensive sessions to review first-half performance, analyze emerging industry trends, and unveil the full “Six Veins Divine Sword” operational framework for the second half of the year, aligning thinking and setting clear direction for the market‑driving phase ahead.

07

2026-07

The “Thousand Counties, Ten Thousand Towns” initiative has established its demonstration site at Xia County People’s Hospital.

On July 7, the on-site exchange meeting for the “Rheumatism and Pain Triple Sequential Therapy—Thousand Counties, Ten Thousand Towns Initiative” was held in the fourth-floor conference room of the Administrative Building at Xia County People’s Hospital. This marked the official establishment of the initiative’s demonstration site at Xia County People’s Hospital, representing a solid step forward in enhancing primary healthcare service capacity in Xia County.

07

2026-07

Ten Years of Steadfast Dedication to Our Original Aspiration, a Century of Refinement in Medicine Ushering in a New Journey | The 100th Session of the Sanlian Sequential Therapy Master Instructor Training Program Concludes Successfully

In July 2026, the mentor training program for the three‑pronged sequential therapy of rheumatology and pain will mark a dual historic milestone: its 10th anniversary and the completion of its 100th session. Senior physicians from key departments across eleven provinces gathered at Hunan Provincial Hospital of Traditional Chinese Medicine to undertake a five‑day, systematic specialized course. Upon successfully completing the program and returning home with substantial professional achievements, they brought a well‑deserved close to this decade‑long initiative to empower physicians.

07

2026-07

Long Xianjun, Member of the Party Committee’s Organization Committee and Rotating President of Zhengqing Group, has been recognized as an Outstanding Communist Party Member in Emerging Fields at the Huaihua municipal level.

On June 30, the CPC Working Committee for New Economic and Social Organizations of the Huaihua Municipal Party Committee convened a city‑level commendation conference for outstanding individuals and exemplary Party organizations in emerging sectors. Long Xianjun, Member of the Party Committee and Rotating President of Zhengqing Group, was awarded the title of “Outstanding Communist Party Member in Emerging Sectors at the City Level.”

< 1234...42 >